A study for a 62 year old woman who takes Sensipar - from FDA reports


Summary

3,390 females aged 62 (±5) who take the same drug are studied. This is a personalized study for a 62 year old female patient who has High Blood Pressure. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 11, 2017

3,390 females aged 62 (±5) who take Sensipar are studied.


Number of reports submitted per year:

Sensipar for a 62-year old woman.

Information of the patient in this study:

  • Age: 62
  • Gender: female
  • Conditions: High Blood Pressure
  • Drugs taken:
    • Sensipar (cinacalcet hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Hypertension: 42 (1.24% of females aged 62 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • nausea and vomiting
  • nausea
  • breathing difficulty
  • confusional state
  • delirium
  • localised oedema
  • diarrhea
  • hypersensitivity
  • weakness
  • death
1 - 6 months:
  • nausea
  • blood calcium decreased
  • hypocalcaemia
  • muscle aches
  • abdominal pain
  • dialysis
  • dizziness
  • abdominal discomfort
  • hypoaesthesia
  • weakness
6 - 12 months:
  • hypoaesthesia
  • fatigue
  • muscle spasms
  • abdominal rigidity
  • hypoglycemia
  • oedema peripheral
  • joint pain
  • large intestine perforation
  • blood parathyroid hormone increased
  • death
1 - 2 years:
  • insomnia
  • pain
  • abdominal pain upper
  • large intestine perforation
  • thalamus haemorrhage
  • joint stiffness
  • skin exfoliation
  • abdominal discomfort
  • synovitis
  • burning sensation
2 - 5 years:
  • atrial fibrillation/flutter
  • gait disturbance
  • bone pain
  • nephrogenic systemic fibrosis
  • muscle tightness
  • pain
  • mobility decreased
  • general physical health deterioration
  • scar
  • quality of life decreased
5 - 10 years:
  • pulmonary hypertension
  • death
10+ years:
n/a
not specified:
  • hospitalisation
  • nausea
  • malaise
  • laboratory test abnormal
  • nausea and vomiting
  • appetite - decreased
  • diarrhea
  • pain
  • weakness
  • dizziness

Top conditions involved for these people *:

  • Hyperparathyroidism (47 people, 1.39%)
  • Hyperphosphataemia (38 people, 1.12%)
  • Nuclear Magnetic Resonance Imaging Brain (32 people, 0.94%)
  • Renal Failure Chronic (31 people, 0.91%)
  • Arteriogram (30 people, 0.88%)

Top co-used drugs for these people *:

  • Renagel (150 people, 4.42%)
  • Renvela (90 people, 2.65%)
  • Coumadin (90 people, 2.65%)
  • Phoslo (87 people, 2.57%)
  • Aspirin (86 people, 2.54%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Hypertension, High blood pressure, Sensipar

You may be interested in these reviews

More reviews for: Hypertension, High blood pressure, Sensipar